Investigator, Lady Davis Institute for Medical Research
Assistant Professor, Department of Oncology, McGill University
Dr. Raquel Aloyz is a scientist in the field of drug resistance in cancer. In the past few years she has focused her research on chronic lymphocytic leukemia and lymphoma using malignant lymphocytes donated by the patients treated at the haematology clinic at the Jewish General Hospital. The focus of her research is to find targeted therapies to treat haematological malignancies using tyrosine kinase inhibitors.